Supply Duration: 90 Day Supply
Standard Dosing Protocol: Weeks 1-4: 100mg twice weekly; week 5 onward: 100mg once weekly (maintenance)
This is standard protocol. The provider has the ability to change protocol based on their medical expertise.
What’s Included:
90-Day Supply
Medical Expertise & Guidance
Prescription grade, from a U.S. Licensed Compound Pharmacy
Reconstituted and ready-to-use
Syringes, supplies and instructions included
Free Expedited Shipping
Glutathione is commonly explored for
Antioxidant defense (oxidative stress support)
Liver detox support (everyday toxin burden)
Immune system support
Skin clarity & overall “glow” support
Recovery support (training, travel, high-stress seasons)
Therapeutic applications
Chronic fatigue syndrome
Autoimmune conditions
Heavy metal toxicity
Liver disease support
Anti-aging and wellness programs
Contraindications and exclusions
Known allergy or hypersensitivity to glutathione or components
Asthma (inhaled forms may trigger bronchospasm)
Organ transplant patients on immunosuppressive therapy
Chemotherapy or radiation patients (certain protocols)
Pregnancy and breastfeeding (insufficient safety data)
Sulfite sensitivity (especially IV or nebulized forms)
Active cancer (consult oncologist first)
Severe renal or hepatic impairment
Clinical & Research References for Glutathione
Forman HJ, Zhang H, Rinna A. Glutathione: Overview of its protective roles, measurement, and biosynthesis. PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC2696075/
Aquilano K, Baldelli S, Ciriolo MR. Glutathione: new roles in redox signaling for an old antioxidant. PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC4144092/
Honda Y, et al. Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease (NAFLD). PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC5549431/
Hauser RA, et al. Randomized, double-blind, pilot evaluation of intravenous glutathione in Parkinson’s disease. PubMed. https://pubmed.ncbi.nlm.nih.gov/19230029/
Mischley LK, et al. Phase IIb Study of Intranasal Glutathione in Parkinson’s Disease. PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC5438472/
Wang HL, et al. Potential use of glutathione as a treatment for Parkinson’s disease (systematic review/meta-analysis). PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC7751460/

